194 related articles for article (PubMed ID: 29707136)
1. BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.
Romano E; Rufo N; Korf H; Mathieu C; Garg AD; Agostinis P
Oncotarget; 2018 Apr; 9(25):17631-17644. PubMed ID: 29707136
[TBL] [Abstract][Full Text] [Related]
2. Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade.
Anderson KL; Snyder KM; Ito D; Lins DC; Mills LJ; Weiskopf K; Ring NG; Ring AM; Shimizu Y; Mescher MF; Weissman IL; Modiano JF
Melanoma Res; 2020 Apr; 30(2):147-158. PubMed ID: 31205227
[TBL] [Abstract][Full Text] [Related]
3. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
4. Chromomycin A
Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
Front Immunol; 2022; 13():941757. PubMed ID: 36439184
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation.
Garg AD; Romano E; Rufo N; Agostinis P
Cell Death Differ; 2016 Jun; 23(6):938-51. PubMed ID: 26891691
[TBL] [Abstract][Full Text] [Related]
6. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton.
Maes H; Van Eygen S; Krysko DV; Vandenabeele P; Nys K; Rillaerts K; Garg AD; Verfaillie T; Agostinis P
Cell Death Dis; 2014 Mar; 5(3):e1127. PubMed ID: 24625986
[TBL] [Abstract][Full Text] [Related]
7. Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.
Kelley SM; Ravichandran KS
EMBO Rep; 2021 Jun; 22(6):e52564. PubMed ID: 34041845
[TBL] [Abstract][Full Text] [Related]
8. BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis.
Vara-Pérez M; Rossi M; Van den Haute C; Maes H; Sassano ML; Venkataramani V; Michalke B; Romano E; Rillaerts K; Garg AD; Schepkens C; Bosisio FM; Wouters J; Oliveira AI; Vangheluwe P; Annaert W; Swinnen JV; Colet JM; van den Oord JJ; Fendt SM; Mazzone M; Agostinis P
EMBO J; 2021 May; 40(10):e106214. PubMed ID: 33932034
[TBL] [Abstract][Full Text] [Related]
9. Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics.
Ramon J; Engelen Y; De Keersmaecker H; Goemaere I; Punj D; Mejía Morales J; Bonte C; Berx G; Hoste E; Stremersch S; Lentacker I; De Smedt SC; Raemdonck K; Braeckmans K
J Control Release; 2024 Jan; 365():1019-1036. PubMed ID: 38065413
[TBL] [Abstract][Full Text] [Related]
10. YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.
von Ofen AJ; Thiel U; Eck J; Gassmann H; Thiede M; Hauer J; Holm PS; Schober SJ
Front Oncol; 2024; 14():1304374. PubMed ID: 38357194
[TBL] [Abstract][Full Text] [Related]
11. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.
Abdel-Bar HM; Walters AA; Lim Y; Rouatbi N; Qin Y; Gheidari F; Han S; Osman R; Wang JT; Al-Jamal KT
Theranostics; 2021; 11(18):8738-8754. PubMed ID: 34522209
[No Abstract] [Full Text] [Related]
12. Improving nanochemoimmunotherapy efficacy by boosting "eat-me" signaling and downregulating "don't-eat-me" signaling with
Pang G; Wei S; Zhao J; Wang FJ
J Mater Chem B; 2023 Dec; 11(48):11562-11577. PubMed ID: 37982298
[TBL] [Abstract][Full Text] [Related]
13. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X
ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330
[TBL] [Abstract][Full Text] [Related]
14. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
15. Targeting HDAC6 improves anti-CD47 immunotherapy.
Gracia-Hernandez M; Yende AS; Gajendran N; Alahmadi Z; Li X; Munoz Z; Tan K; Noonepalle S; Shibata M; Villagra A
J Exp Clin Cancer Res; 2024 Feb; 43(1):60. PubMed ID: 38414061
[TBL] [Abstract][Full Text] [Related]
16. A lectin from Bothrops leucurus snake venom raises cytosolic calcium levels and promotes B16-F10 melanoma necrotic cell death via mitochondrial permeability transition.
Aranda-Souza MA; Rossato FA; Costa RA; Figueira TR; Castilho RF; Guarniere MC; Nunes ES; Coelho LC; Correia MT; Vercesi AE
Toxicon; 2014 May; 82():97-103. PubMed ID: 24593964
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of [
Vermeulen K; Naus E; Ahamed M; Attili B; Siemons M; Luyten K; Celen S; Schymkowitz J; Rousseau F; Bormans G
Theranostics; 2019; 9(2):554-572. PubMed ID: 30809293
[TBL] [Abstract][Full Text] [Related]
18. BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma.
Liu F; Jiang CC; Yan XG; Tseng HY; Wang CY; Zhang YY; Yari H; La T; Farrelly M; Guo ST; Thorne RF; Jin L; Wang Q; Zhang XD
Oncotarget; 2017 Sep; 8(41):69477-69492. PubMed ID: 29050218
[TBL] [Abstract][Full Text] [Related]
19. STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.
Shao X; Wang X; Guo X; Jiang K; Ye T; Chen J; Fang J; Gu L; Wang S; Zhang G; Meng S; Xu Q
Front Oncol; 2019; 9():436. PubMed ID: 31192135
[No Abstract] [Full Text] [Related]
20. DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
Cendrowicz E; Jacob L; Greenwald S; Tamir A; Pecker I; Tabakman R; Ghantous L; Tamir L; Kahn R; Avichzer J; Aronin A; Amsili S; Zorde-Khvalevsky E; Gozlan Y; Vlaming M; Huls G; van Meerten T; Dranitzki ME; Foley-Comer A; Pereg Y; Peled A; Chajut A; Bremer E
J Exp Clin Cancer Res; 2022 Mar; 41(1):97. PubMed ID: 35287686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
